Dr Christopher Winter is currently Managing Partner at Brightstar Partners Ltd, a venture capital firm and Chair of InterMedi Group. Both organisations specialise in spinning out technology developed in the UK National Health Service (NHS).
Chris is also Chairman of NeuDrive Ltd, a biosensor/big data company and sits on the board of Regenerys, a UK-based regenerative medicine company backed by angel capital. He acts as investment advisor to Alderley Park Ventures and the Cambridge University Seed Fund.
Through his career, which includes being a partner at New Venture Partners, a transatlantic venture capital fund spinning technologies out of corporate labs. Chris has been involved in around 45 high tech spinouts and investments. This includes five $80m+ exits.
Chris combines broad, deep technical knowledge with significant commercial expertise focussed on IP based spinouts and a broad understanding how technology can change the way we work and play.
Want to learn more?
If you are interested in our products and services and would like to learn more, or have a project you would like to discuss with us, then please get in touch.